NCT06868927 Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
| NCT ID | NCT06868927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Renal Tumors |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-26 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-09-26 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indicative of response to systemic agents or ablative therapy.
Eligibility Criteria
Inclusion Criteria: * Presence of a renal mass up to 4 cm * Adult \> 18 years * Candidate to renal surgery * Informed consent signed Exclusion Criteria: * Contraindication for MRI
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06868927 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Renal Tumors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06868927 currently recruiting?
Yes, NCT06868927 is actively recruiting participants. Contact the research team at caitanio.umberto@hsr.it for enrollment information.
Where is the NCT06868927 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06868927 clinical trial?
NCT06868927 is sponsored by IRCCS San Raffaele. The trial plans to enroll 50 participants.